Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome

Ulrik Fahnøe, Martin S. Pedersen, Christina Sølund, Anja Ernst, Henrik B. Krarup, Birgit T. Røge, Peer B. Christensen, Alex L. Laursen, Jan Gerstoft, Peter Thielsen, Lone G. Madsen, Anders G. Pedersen, Kristian Schønning, Nina Weis, Jens Bukh^*